As part of Cheddar's partnership with WeWork, we are introducing our viewers to start-up founders disrupting industries. The three co-founders of photo-sharing platform Blurr Technologies, Sam Marley, Daniel Korman, and Daniel Arvidsson, join to discuss how they were inspired to launch their company in college.
The founders of Blurr Technologies were freshman-year roommates at Northeastern University, hailing from three different continents. They were also teammates on the varsity soccer team. Marley says they were inspired to launch this company after experiencing how difficult it was to get access to photos taken around them in college. So they launched a photo-based sharing app. Now, the company is shifting gears to offer a business-to-business solution for events.
Blurr Technologies creates a geo-fence around events, and every picture taken by anyone is added to the shared album through this platform. Korman says their technology goes beyond a shared hashtag, because the user experience is frictionless. The company has since raised $250,000 in funding, and is a member of the WeWork community.
Nugget ice is booming across America. Middleby CEO Tim FitzGerald explains the craze, restaurant demand and why the trend could become a major growth engine.
Wearable robotics are moving beyond sci-fi. Dephy CEO Luke Mooney explains how its smart ankle exoskeleton is changing mobility, recovery and everyday movement.
Voice AI is moving into cars, restaurants and customer service. SoundHound CEO Keyvan Mohajer explains the company’s growth and the future of voice-powered AI.
Americans are still spending, but rising anxiety over jobs, AI, housing and tariffs tells a different story. Kearney Consumer Institute’s Katie Thomas explains.
Disney is back in focus after Q3 earnings. Investors are watching streaming profits, theme parks and ESPN as the entertainment giant looks for its next catalyst
Healthcare policy is shifting fast, raising questions about drug prices, Medicare and access. Leap Health CEO Hani Elias explains what patients need to know.